Imlunestrant with or without everolimus or alpelisib, in ER+, HER2-advanced breast cancer (aBC): Results from the phase Ia/b EMBER Meeting Abstract
| Authors: | Jhaveri, K.; Jeselsohn, R.; Ma, C. X.; Lim, E.; Yonemori, K.; Hamilton, E. P.; Harnden, K.; Im, S. A.; Beck, T.; Sammons, S.; Bhave, M.; Kaufman, P. A.; Manich, C. S.; Meniawy, T.; Bacchion, F.; Ismail-Khan, R.; Li, Y.; Estrem, S. T.; Nguyen, B.; Beeram, M. |
| Abstract Title: | Imlunestrant with or without everolimus or alpelisib, in ER+, HER2-advanced breast cancer (aBC): Results from the phase Ia/b EMBER |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S338 |
| End Page: | S339 |
| Language: | English |
| ACCESSION: | WOS:001087480200372 |
| DOI: | 10.1016/j.annonc.2023.09.560 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 383O -- Source: Wos |
